• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物递送产品与速溶片剂型(Zydis)

Drug-delivery products and the Zydis fast-dissolving dosage form.

作者信息

Seager H

机构信息

Scherer DDS, Blagrove, Swindon, Wiltshire, UK.

出版信息

J Pharm Pharmacol. 1998 Apr;50(4):375-82. doi: 10.1111/j.2042-7158.1998.tb06876.x.

DOI:10.1111/j.2042-7158.1998.tb06876.x
PMID:9625481
Abstract

Many patients find it difficult to swallow tablets and hard gelatin capsules and do not take their medication as prescribed. It is estimated that 50% of the population is affected by this problem which results in a high incidence of non-compliance and ineffective therapy. The difficulty is experienced in particular by paediatric and geriatric patients, but it also applies to people who are ill in bed and to those active working patients who are busy or travelling, especially those who have no access to water. Such problems can be resolved by means of the Zydis dosage form which does not require water to aid swallowing. The Zydis fast-dissolving dosage form is a unique freeze dried medicinal tablet, made from well known and acceptable materials. When Zydis units are put into the mouth, the freeze dried structure disintegrates instantaneously releasing the drug which dissolves or disperses in the saliva. The saliva containing the dissolved or dispersed medicament is then swallowed and the drug is absorbed in the normal way. Some drugs are absorbed from the mouth, pharynx and oesophagus as the saliva passes down into the stomach. In these cases, the bioavailabilities of drugs from Zydis formulations are significantly greater than those observed from standard dosage forms. This paper deals with the formulation and process technology of the Zydis dosage form. The bioavailability characteristics of Zydis products are summarized, and in particular, the design of Zydis products for the enhancement of oral bioavailability and the improvement of clinical activity, through transmucosal delivery and pregastric absorption, is discussed.

摘要

许多患者觉得吞咽片剂和硬明胶胶囊困难,因而不按医嘱服药。据估计,50%的人口受此问题影响,这导致了高比例的不依从性和无效治疗。尤其是儿科和老年患者会遇到这种困难,但卧床患者以及忙碌或出行的在职患者(特别是那些无法获取水的患者)也会有此问题。借助无需用水辅助吞咽的齐迪斯(Zydis)剂型可解决此类问题。齐迪斯速溶剂型是一种独特的冻干药片片剂,由知名且可接受的材料制成。当将齐迪斯制剂放入口中时,冻干结构会瞬间崩解,释放出药物,药物在唾液中溶解或分散。然后含溶解或分散药物的唾液被咽下,药物以正常方式被吸收。随着唾液流入胃中,一些药物会从口腔、咽部和食管吸收。在这些情况下,齐迪斯制剂中药物的生物利用度显著高于标准剂型。本文论述了齐迪斯剂型的制剂和工艺技术。总结了齐迪斯产品的生物利用度特征,尤其讨论了通过透粘膜给药和胃前吸收来提高口服生物利用度及改善临床活性的齐迪斯产品设计。

相似文献

1
Drug-delivery products and the Zydis fast-dissolving dosage form.药物递送产品与速溶片剂型(Zydis)
J Pharm Pharmacol. 1998 Apr;50(4):375-82. doi: 10.1111/j.2042-7158.1998.tb06876.x.
2
A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition.司来吉兰的一种新的低剂量制剂:临床疗效、患者偏好及对单胺氧化酶B抑制的选择性。
J Neural Transm (Vienna). 2003 Nov;110(11):1257-71. doi: 10.1007/s00702-003-0042-6.
3
Freeze dried ondansetron: first observations with the fast dissolving oral antiemetic Zofran Zydis for the prophylaxis of the cisplatin-induced emesis in gynecological cancer patients.冻干昂丹司琼:关于快速溶解口服止吐药枢复宁速溶片预防妇科癌症患者顺铂所致呕吐的初步观察。
Neoplasma. 2002;49(2):126-8.
4
Comprehensive review on oral disintegrating films.口腔崩解片的综合评述。
Curr Drug Deliv. 2013 Feb;10(1):96-108. doi: 10.2174/1567201811310010016.
5
A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition.司来吉兰的新剂型:提高生物利用度及对单胺氧化酶B抑制的选择性。
J Neural Transm (Vienna). 2003 Nov;110(11):1241-55. doi: 10.1007/s00702-003-0036-4.
6
An introduction to fast dissolving oral thin film drug delivery systems: a review.快速溶解口腔薄膜给药系统简介:综述
Curr Drug Deliv. 2013 Dec;10(6):667-84. doi: 10.2174/156720181006131125150249.
7
Fast dissolving films: a review.速溶薄膜:综述。
Curr Drug Deliv. 2011 Jul;8(4):373-80. doi: 10.2174/156720111795768022.
8
[Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].[双氯芬酸钠缓释制剂中所选药物的技术和药物治疗特性]
Polim Med. 2012;42(2):121-32.
9
Lansoprazole fast disintegrating tablet: a new formulation for an established proton pump inhibitor.兰索拉唑速崩片:一种已上市质子泵抑制剂的新剂型。
Digestion. 2003;67(1-2):1-5. doi: 10.1159/000070393.
10
[Research progress on the oral solid rapidly disintegrating dosage form].[口腔固体速崩型剂型的研究进展]
Zhongguo Zhong Yao Za Zhi. 2005 Jan;30(2):89-92.

引用本文的文献

1
Contributions of pharmaceutical interventions to the multidisciplinary dysphagia team: A retrospective observational study.药物干预对多学科吞咽困难治疗团队的贡献:一项回顾性观察研究。
J Pharm Health Care Sci. 2025 Aug 5;11(1):66. doi: 10.1186/s40780-025-00474-x.
2
Freeze-Drying as a Tool for Preparing Porous Materials: From Proof of Concept to Recent Pharmaceutical Applications.冷冻干燥作为制备多孔材料的工具:从概念验证到近期的药物应用
AAPS PharmSciTech. 2025 Jun 3;26(5):159. doi: 10.1208/s12249-025-03117-4.
3
Diclofenac-Loaded Orodispersible Nanofibers Prepared by Double-Needle Electrospinning.
通过双针静电纺丝制备的载双氯芬酸口腔崩解纳米纤维
Polymers (Basel). 2025 May 6;17(9):1262. doi: 10.3390/polym17091262.
4
Next-generation pharmaceuticals: the rise of sildenafil citrate ODF for the treatment of men with erectile dysfunction.下一代药物:枸橼酸西地那非口腔崩解片用于治疗男性勃起功能障碍的兴起。
Ther Deliv. 2025 Apr;16(4):365-378. doi: 10.1080/20415990.2024.2445501. Epub 2025 Jan 12.
5
Formulation and characterization of lamotrigine nasal insert targeted brain for enhanced epilepsy treatment.拉莫三嗪鼻腔给药递药系统用于治疗癫痫的研究
Drug Deliv. 2023 Dec;30(1):2163321. doi: 10.1080/10717544.2022.2163321.
6
Central Composite Designed Fast Dissolving Tablets for Improved Solubility of the Loaded Drug Ondansetron Hydrochloride.中心复合设计快速分散片提高盐酸昂丹司琼负载药物的溶解度。
Biomed Res Int. 2022 Aug 21;2022:2467574. doi: 10.1155/2022/2467574. eCollection 2022.
7
Orally Dispersible Dosage Forms for Paediatric Use: Current Knowledge and Development of Nanostructure-Based Formulations.儿科用口腔崩解剂型:当前认知及基于纳米结构制剂的开发
Pharmaceutics. 2022 Aug 3;14(8):1621. doi: 10.3390/pharmaceutics14081621.
8
A critical appraisal of MAO-B inhibitors in the treatment of Parkinson's disease.MAO-B 抑制剂治疗帕金森病的关键性评价。
J Neural Transm (Vienna). 2022 Jun;129(5-6):723-736. doi: 10.1007/s00702-022-02465-w. Epub 2022 Feb 2.
9
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain.大麻素制剂和给药系统:治疗疼痛的当前和未来选择。
Drugs. 2021 Sep;81(13):1513-1557. doi: 10.1007/s40265-021-01579-x. Epub 2021 Sep 4.
10
Patient Centric Pharmaceutical Drug Product Design-The Impact on Medication Adherence.以患者为中心的药品设计——对药物依从性的影响。
Pharmaceutics. 2020 Jan 3;12(1):44. doi: 10.3390/pharmaceutics12010044.